Verenium Corporation (VRNM)

BASF Enzymes LLC engages in the development and commercialization of enzymes for industrial processes in North America, Europe, South America, and Asia. The company manufactures and markets its proprietary enzyme products in the fields of animal health and nutrition, grain processing, oilfield services, and other industrial processes. Its animal health and nutrition product is Phyzyme XP phytase, an enzyme added to poultry and swine feed that promotes growth by enhancing the nutrition that animals extract from feed grains. The company’s grain processing products comprise Fuelzyme alpha-amylase, an enzyme for starch liquefaction in the production of fuel ethanol and other industrial-use alcohols; DELTAZYM GA L-E5, a high-activity glucoamylase for the conversion of starch to sugars in fuel ethanol production; and Xylathin xylanase, an enzyme that enhances the efficiency of fuel ethanol production from cereal grains. Its oilfield services products include Pyrolase cellulase and Pyrolase HT cellulase and Eradicake alpha-amylase enzyme, which breaks down starch. The company’s other industrial processes products comprise Cottonase pectate lyase, a textile processing enzyme for cotton; and Luminase PB-100 xylanase, which enhances the reactivity of pulp fiber to bleaching chemicals. It also has enzyme product candidates in various stages of development for animal health and nutrition, grain and starch processing, and oilfield services markets. In addition, the company provides contract manufacturing services. It has a strategic collaboration with Novus International, Inc. BASF Enzymes LLC was formerly known as Verenium Corporation. The company was incorporated in 1992 and is based in Cambridge, Massachusetts. BASF Enzymes LLC operates as a subsidiary of BASF SE.